Drug
ZSP1273 clinical trials
Also written ZSP1273.
- studies test it
- 14
- open now
- 0
- in phase 3
- 3
- first study started
- 2018
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
14 studies that test it; most in 2023 (6)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2023 | 6 |
| 2024 | 2 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 9
- Phase 2
- 2
- Phase 3
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 14 · Other 0
Guangdong Raynovent Biotech Co., Ltd (13) · Guangdong Zhongsheng Pharmaceutical Co., Ltd. (1)
Often tested with
Tested in the same studies.
Digoxin (1) · Rosuvastatin (1) · Itraconazole (1) · Probenecid (1) · Oseltamivir (1)
Studies
Open first, then newest update. How each study uses ZSP1273 is read from its arms, and is right about nine times in ten.
Testing it · 14
- Efficacy and Safety of ZSP1273 in Children 2-11 Years Old With Influenza AActive, not recruitingPhase 3Guangdong Raynovent Biotech Co., LtdNCT07229807Written as ZSP1273
- Efficacy and Safety of ZSP1273 in Children 12-17 Years Old With Influenza AActive, not recruitingPhase 3Guangdong Raynovent Biotech Co., LtdNCT07229820Written as ZSP1273
- Pharmacokinetics,Safety and Efficacy of ZSP1273 in Children 2-17 Years Old With Influenza ACompletedPhase 2Guangdong Raynovent Biotech Co., LtdNCT06656026Written as ZSP1273 granules
- Mass Balance Study of [14C]ZSP1273 in Healthy Adult Male Subjects in ChinaCompletedPhase 1Guangdong Raynovent Biotech Co., LtdNCT05873426Written as [14C] ZSP1273
- Pharmacokinetics of ZSP1273 in Participants With Severe Kidney DiseaseCompletedPhase 1Guangdong Raynovent Biotech Co., LtdNCT06248567Written as ZSP1273
- Bioavailability Study in Healthy Participants, 200mg Tablets ZSP1273 Versus 200mg Granules ZSP1273CompletedPhase 1Guangdong Raynovent Biotech Co., LtdNCT06164431Written as ZSP1273 tablet
- Drug-durg Interaction of ZSP1273 With Digoxin, Rosuvastatin,Itraconazole and ProbenecidCompletedPhase 1Guangdong Raynovent Biotech Co., LtdNCT05954624Written as ZSP1273
- A Drug Interaction Study Assess the Effects of ZSP1273 Tablets on the Pharmacokinetics of Warfarin and MidazolamCompletedPhase 1Guangdong Raynovent Biotech Co., LtdNCT05942365Written as ZSP1273
- Pharmacokinetics of ZSP1273 in Elder ParticipantsCompletedPhase 1Guangdong Raynovent Biotech Co., LtdNCT06157450Written as ZSP1273
- Pharmacokinetics of ZSP1273 in Participants With Hepatic ImpairmentCompletedPhase 1Guangdong Raynovent Biotech Co., LtdNCT05856513Written as ZSP1273
- A Study of ZSP1273 Tablets in Patients With Acute Uncomplicated Influenza ACompletedPhase 3Guangdong Raynovent Biotech Co., LtdNCT04683406Written as ZSP1273 600 mg
- Study to Investigate the Potential Drug-Drug Interaction Between ZSP1273 and OseltamivirCompletedPhase 1Guangdong Raynovent Biotech Co., LtdNCT05108051Written as ZSP1273
- Study of ZSP1273 in Patients With Acute Uncomplicated Influenza ACompletedPhase 2Guangdong Raynovent Biotech Co., LtdNCT04024137Written as ZSP1273 200 mg
- The Safety, Tolerability and Pharmacokinetic Study of ZSP1273 in Healthy Volunteers.CompletedPhase 1Guangdong Zhongsheng Pharmaceutical Co., Ltd.NCT03679143Written as ZSP1273 100 mg